Company

VIVUS INC (0000881524)

Standardized SEC financial data for VIVUS INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000881524 · Pharmaceutical Preparations.

Gross margin

73.7%

Operating margin

-16.8%

Net margin

-48.2%

Revenue growth (YoY)

-47.4%

Return on equity

45.5%

ROIC

-2.7%

Free cash flow

-$30.5M

Debt / equity

-6.14×

Ratios for fiscal year 2017, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018	FY2019
Revenue	$124.3M	$65.4M	—	—
Cost of revenue	$10.6M	$17.2M	$14.6M	$15.7M
Gross profit	$113.7M	$48.2M	—	—
R&D expense	$5.6M	$5.3M	$7.3M

Get 0000881524 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000881524/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000881524/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000881524 filings on SEC EDGAR →